Research use only • Not for human or veterinary use Peptide research material · Liquid vial format Grindlab Retatrutide ``` Grindlab Retatrutide is supplied as a clearly labelled single-compound research material containing 10 mg in a 10 ml vial. Presented in a clean laboratory format with straightforward specifications for identification, organisation and controlled research environments. Research vial 10 mg · 10 ml Retatrutide Product information Research overview Research material Product Retatrutide Strength 10 mg Volume 10 ml Format Research vial Scope Laboratory research only ``` Strength 10 mg labelled Retatrutide content ``` Volume 10 ml supplied per vial Format Single compound clearly identified material Scope RUO no human or veterinary use ``` Product information Clearly specified Retatrutide research material ``` Each vial is labelled as Retatrutide with a total stated strength of 10 mg and a total volume of 10 ml. The product is presented as a single-compound research material so the identity, quantity and format can be reviewed directly and efficiently. Labelled strength 10 mg Total labelled Retatrutide content supplied in each research vial. Volume 10 ml Supplied in a clearly labelled laboratory vial designed for straightforward product identification. Material format Research vial Single-compound Retatrutide material supplied specifically for non-clinical laboratory research. ``` Product design Clear specifications. Defined research scope. ``` The Grindlab research range is structured around transparent product presentation, with the compound name, labelled strength, volume and intended research scope displayed prominently. 01 Clearly labelled Retatrutide, total strength and vial volume are stated directly for straightforward identification. 02 Single compound The vial is presented as a standalone Retatrutide research material rather than as part of a multi-compound formulation. 03 Research-first presentation Product information focuses on material identity and specifications without medical, therapeutic or performance claims. ``` Research overview Retatrutide in laboratory research ``` Retatrutide is a peptide-based investigational research compound that has attracted scientific interest in receptor-signalling and metabolic research models. It is studied in controlled experimental settings to better understand its molecular activity and interaction with multiple biological signalling pathways. 01 Compound Retatrutide is an investigational peptide research compound designed to interact with multiple receptor-signalling pathways. 02 Research interest Scientific investigation has focused on its activity across GLP-1, GIP and glucagon receptor systems in experimental research. 03 Controlled investigation Materials of this type are used in appropriately designed laboratory and analytical research environments. 04 Defined scope Grindlab Retatrutide is supplied solely as a research material and is not presented as a medicine, supplement or therapeutic product. ``` Product questions Frequently asked questions ``` What product is included? Each vial contains material labelled as Grindlab Retatrutide, supplied as a single-compound research product. What strength is supplied? Each vial is labelled with a total Retatrutide strength of 10 mg. What volume is supplied? Each vial contains a labelled total volume of 10 ml. What is Retatrutide? Retatrutide is an investigational peptide research compound studied for its interaction with GLP-1, GIP and glucagon receptor-signalling pathways. Is this a medicinal product? No. Grindlab Retatrutide is supplied strictly as a laboratory research material and is not marketed as a medicinal or therapeutic product. What is the intended use? This material is supplied solely for laboratory research purposes and is not intended for human or veterinary consumption or administration. ``` Research use only Grindlab Retatrutide is supplied solely as a laboratory research material. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or performance enhancement. No representation is made regarding safety or effectiveness in humans.